[Heparinoids in the treatment of dyslipemia in patients with diabetic vasculopathy: action of 3gs].
D000328:Adult; D000368:Aged; D003925:Diabetic Angiopathies / Q000150:complications*; D004341:Drug Evaluation; D005260:Female; D005965:Glucuronates / Q000627:therapeutic use; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006496:Heparinoids / Q000627:therapeutic use*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood
D005965:Glucuronates; D006025:Glycosaminoglycans; D006496:Heparinoids; D014280:Triglycerides
Gli eparinodi nel trattamento della dislipemia di diabetici vasculopatici: attivita del 3GS.